Early Onset Alzheimer's Trial

For nearly 10 years, MRN has worked with Washington University School of Medicine in St. Louis to provide clinical services to participants enrolled in international clinical trials that are evaluating whether investigational drugs can slow or prevent a rare form of Alzheimer's disease in people genetically destined to develop the illness at a young age.

Washington University is the leading DIAN-TU (Dominantly inherited Alzheimer's Network Trials Unit) trials, and MRN provides clinical trials support to participants in their homes. 

Global forces in clinical research

With extensive expertise in clinical trial support and the delivery of patient care in clinical research, MRN's initial remit was to manage home trial support for participants in the UK, Europe and Australia. The MRN team quickly demonstrated its capabilities and then assumed the management of the study's clinical trial nurses and participants in North America in December 2018. Since then, the team has worked together with Washington University to deliver clinical services to more than 104 participants worldwide.

To learn more about MRN, visit their Clinical Leader page.